Listed

Collegium Pharmaceutical, Inc: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 8, 2019 and accepted by EDGAR at May 8, 2019, 16:03 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-01-01 to 2019-03-31$74.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-01-01 to 2019-03-31$49.2mus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2019-01-01 to 2019-03-31$3.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-01-01 to 2019-03-31$32.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-01-01 to 2019-03-31−$10.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-01-01 to 2019-03-31$234.0kus-gaap:InterestExpense
Net income3 months2019-01-01 to 2019-03-31−$9.7mus-gaap:NetIncomeLoss
Operating cash flow3 months2019-01-01 to 2019-03-31−$8.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2019-01-01 to 2019-03-31$3.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-03-31$134.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$233.8mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$294.4mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$188.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$208.0mus-gaap:Liabilities
Long-term debtAt period end2019-03-31$11.5mus-gaap:LongTermDebt
Shareholders' equityAt period end2019-03-31$86.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-19-004446. Last ingested by Listed: Nov 10, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.